Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing Dosing Strategies in Oral Iron Supplementation
NCT06238895Phase 4Completed
- Sponsor
- Luzerner Kantonsspital
- Start
- Mar 2024
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ferrous sulfate in iron deficiency anemia (IDA) (2 arms), sponsored by Luzerner Kantonsspital. Primary endpoint: Change of Hemoglobin at 12 weeks. Started Mar 2024; status: completed.
02
Drugs
ferrous sulfate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT06238895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06238895.